Ym2 inhibitors are chemical compounds designed to specifically target and inhibit the activity of Ym2, a member of the chitinase-like protein family. While Ym2 lacks the enzymatic activity typically associated with true chitinases, it still binds chitin-like molecules and is implicated in processes related to tissue remodeling and cellular signaling. The Ym2 protein, along with its family members, is expressed in certain tissues and under specific physiological conditions, often in response to environmental cues. This protein is part of a broader class of lectin-like proteins that contribute to cellular interactions with extracellular matrix components, thus playing a role in maintaining structural and functional integrity at the cellular and tissue levels.
Inhibitors of Ym2 function by binding to the protein and blocking its ability to interact with chitin-like substrates or other molecular partners, thereby disrupting its role in extracellular matrix remodeling or cellular signaling pathways. These inhibitors can modulate how cells respond to external signals related to tissue structure or damage, impacting cellular adhesion, migration, and overall homeostasis. Since Ym2 is involved in protein-protein and protein-carbohydrate interactions, inhibition of its activity could have significant effects on cellular communication and structural maintenance, particularly in tissues that are actively undergoing remodeling or repair. The precise structural characteristics of Ym2 inhibitors and their interaction with the protein are essential for understanding how these compounds can alter Ym2's role in cellular processes, including its contribution to extracellular matrix dynamics and other associated pathways.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D inhibits RNA synthesis, potentially reducing the transcription of chitinase-like 4 and hence its expression. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide inhibits protein synthesis, which may lead to reduced translation of chitinase-like 4, resulting in decreased expression. | ||||||
Puromycin dihydrochloride | 58-58-2 | sc-108071 sc-108071B sc-108071C sc-108071A | 25 mg 250 mg 1 g 50 mg | $42.00 $214.00 $832.00 $66.00 | 394 | |
Puromycin is an inhibitor of protein synthesis, potentially reducing the translation of chitinase-like 4 and leading to decreased expression. | ||||||
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $97.00 $328.00 $676.00 $1467.00 | 6 | |
Rifampicin inhibits bacterial RNA polymerase, which may indirectly affect chitinase-like 4 expression by reducing its transcription. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Sorafenib inhibits several kinases involved in cell signaling pathways, potentially affecting the expression of chitinase-like 4 at a post-translational level. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin inhibits phosphatidylinositol 3-kinase (PI3K), a protein involved in various cellular functions, potentially affecting the expression of chitinase-like 4. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin inhibits protein glycosylation, which may disrupt the folding and trafficking of chitinase-like 4, leading to reduced expression. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts protein transport from the endoplasmic reticulum to the Golgi apparatus, potentially causing retention of chitinase-like 4 within the ER and reducing its expression. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
Geldanamycin inhibits Hsp90, a chaperone protein involved in folding and stabilization of chitinase-like 4, potentially leading to reduced expression. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Monensin disrupts ion gradients across cell membranes, potentially affecting the membrane localization of chitinase-like 4 and reducing its expression. | ||||||